(Press-News.org) The Wake Forest Institute for Regenerative Medicine (WFIRM) proudly announces the appointment of Tim Bertram, PhD, as its new Chief Ecosystem Officer. He will serve as the Chief Executive Officer (CEO) of the U.S. National Science Foundation (NSF) multi-million-dollar long-term investment in commercializing advanced regenerative medical technologies from leading North Carolina academic institutions. With an illustrious career marked by innovation and leadership, Bertram brings decades of transformative experience from his tenure at ProKidney, a leading chronic kidney disease therapy company he founded focused on preserving kidney function and controlling kidney failure.
As the founder and former CEO of ProKidney, Bertram orchestrated the company's growth trajectory, establishing it as a prominent player in the biomedical research field. His visionary leadership and strategic acumen not only propelled ProKidney to success in establishing a global registrational program of regenerative technologies but also positioned it at the forefront of cutting-edge medical advancements. ProKidney, situated in North Carolina’s core brought exceptional workforce development opportunities to the area and continued the state’s legacy in research growth, advanced technology development, manufacturing, and clinical trials.
"We are thrilled to welcome Tim Bertram to WFIRM and our NSF Innovation Engine," said Dr. Anthony Atala, Chief Innovation Officer for the NSF Cooperative Agreement and Director of the Wake Forest Institute for Regenerative Medicine. "His exceptional track record in driving innovation and fostering strategic partnerships makes him the ideal leader to steer the NSF Cooperative Agreement through its next phase of growth."
Prior to founding ProKidney, Bertram held pivotal roles in various capacities, with a deep-rooted commitment to advancing science and technology, with companies such as inRegen, Tengion, Inc., and Pfizer helping to bring 8 new medicines into the marketplace. His appointment solidifies North Carolina’s core academic research institution’s commitment to harnessing innovation for societal impact and addressing global challenges through technology-driven solutions.
"I am honored to join WFIRM and the NSF Innovation Engine at such an exciting time," said Bertram. "Together, I know we can accelerate the development and deployment of transformative technologies for North Carolina and eventually the global market bringing economic growth to the region with this rapidly expanding industry"
Tim Bertram graduated from Iowa State University with a degree in Biology before gaining his Doctor of Veterinary Medicine and PhD in Cellular Pathology from the same institution. He completed Post-doctoral Research in cytokine biology with the NIH and is board certified with the American College Veterinary Pathology (DACVP). He is the current holder of 71 issued patients with 74 pending applications, and in 2023, he was honored as a runner up for the Ernst & Young Entrepreneur of the Year award.
WFIRM is the recipient of the 2024 inaugural NSF Engines Program award. The NSF-Piedmont Triad Regenerative Medicine Engine is an initiative to build a regional innovation ecosystem to accelerate the translation of regenerative medicine use-inspired research to commercialization, thus stimulating economic growth, workforce development, and job creation. CoCore team partners include North Carolina Agricultural and Technical State University, Winston Salem State University, Forsyth Technical Community College, Axiom Space, and the RegenMed Development Organization (ReMDO), and is supported by multiple businesses, governmental entities, and not-for-profit agencies.
About Wake Forest Institute for Regenerative Medicine: The Wake Forest Institute for Regenerative Medicine is recognized as an international leader in translating scientific discovery into clinical therapies, with many world firsts, including the development and implantation of the first engineered organ in a patient. Over 500 people at the institute, the largest in the world, work on more than 40 different tissues and organs. A number of the basic principles of tissue engineering and regenerative medicine were first developed at the institute. WFIRM researchers have successfully engineered replacement tissues and organs in all four categories – flat structures, tubular tissues, hollow organs and solid organs – and 17 different applications of cell/tissue therapy technologies, such as skin, urethras, cartilage, bladders, muscle, kidney, and vaginal organs, have been successfully used in human patients. The institute, which is part of Wake Forest University School of Medicine, is located in the Innovation Quarter in downtown Winston-Salem, NC, and is driven by the urgent needs of patients. The institute is making a global difference in regenerative medicine through collaborations with over 500 entities and institutions worldwide, through its government, academic and industry partnerships, its start-up entities, and through major initiatives in breakthrough technologies, such as tissue engineering, cell therapies, diagnostics, drug discovery, biomanufacturing, nanotechnology, gene editing and 3D printing. Learn more at WFIRM.org.
END
Biotech executive and serial entrepreneur appointed to lead NSF program commercializing technologies from leading North Carolina institutions
2024-08-29
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
NEC Society recognizes a decade of impact
2024-08-29
Davis, CA — The NEC Society, a nonprofit organization dedicated to preventing necrotizing enterocolitis (NEC), a devastating neonatal intestinal disease, proudly marks its 10th anniversary. Founded by Jennifer Canvasser after the tragic loss of her son, Micah, the organization works tirelessly to build a world without NEC, the disease that killed her child and claims another child every day in the United States.
Canvasser shares, "Ten years ago, patient-families affected by NEC were isolated, and clinician-scientists worked in silos. Over the past decade, we've built an empowered community dedicated to transforming our pain into power and isolation into collaboration.”
Since ...
Analysis shows how unproven therapeutics were portrayed in the media during the early phase of COVID-19 pandemic
2024-08-29
WINSTON-SALEM, N.C. – Aug. 29, 2024 – A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and the uncertainty surrounding three unproven therapeutics were portrayed by the U.S. news media during the early days of the COVID-19 pandemic.
The findings appear online in the Journal of Medical Internet Research Infodemiology.
For the study, the researchers conducted an analysis of 479 reports of hydroxychloroquine, remdesivir and/or convalescent plasma in traditional and online U.S. ...
Wang investigates dynamic electron spins in correlated magnets
2024-08-29
This summer, Yishu Wang was awarded a $719,000 research grant from the United States Department of Energy (DOE) to study the dynamic and microscopic behaviors of magnets with quantum mechanical properties.
Magnetism originates from electrons in a material. When the electrons in a material all spin in the same direction, as they do in metals like iron, the material is magnetic, with poles that attract or repel other magnetic materials.
“Magnets that we are using today can be viewed as static orderings of electrons, analogous to the static pattern of brushstrokes in a painting,” said Wang, a joint assistant professor in the Department of Materials Science and Engineering ...
Silicon chip propels 6G communications forward
2024-08-29
Terahertz communications represent the next frontier in wireless technology, promising data transmission rates far exceeding current systems.
By operating at terahertz frequencies, these systems can support unprecedented bandwidth, enabling ultra-fast wireless communication and data transfer. However, one of the significant challenges in terahertz communications is effectively managing and utilising the available spectrum.
The team has developed the first integrated terahertz polarisation (de)multiplexer implemented on a substrateless silicon base which they have successfully tested in the sub-terahertz J-band (220-330 GHz) for 6G communications and beyond.
The University of Adelaide’s ...
Community college students conduct research at UTA
2024-08-29
Studies have shown that undergraduate students who participate in research activities under the guidance of a faculty mentor are more likely to finish college. That’s one of the many reasons universities like The University of Texas at Arlington are increasing their investment into undergraduate research.
Such research opportunities are not offered at many two-year colleges. To help bridge this gap, Jianzhong Su, professor of mathematics at UTA, is piloting a new program where students from the North Lake campus of Dallas College can come to UT Arlington to participate in a paid research ...
VENUS rising: A new dawn for AI-powered atomic-scale 3D imaging
2024-08-29
The Department of Energy’s Oak Ridge National Laboratory added a new neutron scattering instrument to its powerhouse of discovery at the Spallation Neutron Source, charting new territory for neutron imaging through artificial intelligence. In July, DOE’s Office of Science approved the final commissioning of the Versatile Neutron Imaging Instrument, or VENUS.
“It’s a dream come true,” said ORNL neutron scattering scientist Hassina Bilheux. “It has been an honor and privilege to ...
Machine learning helps identify rheumatoid arthritis subtypes
2024-08-29
A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to improve care for the complex condition.
The study published Aug. 29 in Nature Communications shows that artificial intelligence and machine learning technologies can effectively and efficiently subtype pathology samples from patients with RA.
“Our tool automates the analysis of pathology slides, which may one day lead to more precise and efficient disease diagnosis and personalized treatment for ...
Ancient gene gives spiders their narrow waist
2024-08-29
An ancient gene is crucial for the development of the distinctive waist that divides the spider body plan in two, according to a study publishing August 29th in the open-access journal PLOS Biology by Emily Setton from the University of Wisconsin-Madison, US, and colleagues.
The spider body is divided into two sections, separated by a narrow waist. Compared to insects and crustaceans, relatively little is known about embryonic development in spiders, and the genes involved in the formation of the spider waist are poorly understood.
To investigate, researchers sequenced genes expressed in embryos of the Texas brown tarantula (Aphonopelma hentzi) ...
How a salt giant radically reshaped Mediterranean marine biodiversity
2024-08-29
A new study paves the way to understanding biotic recovery after an ecological crisis in the Mediterranean Sea about 5.5 million years ago. An international team led by Konstantina Agiadi from the University of Vienna has now been able to quantify how marine biota was impacted by the salinization of the Mediterranean: Only 11 percent of the endemic species survived the crisis, and the biodiversity did not recover for at least another 1.7 million years. The study was just published in the renowned journal Science.
Lithospheric movements throughout Earth history have repeatedly led to the isolation of regional seas from the ...
Bacteria able to overcome cost of vancomycin resistance in lab setting
2024-08-29
Staphylococcus aureus has the potential to develop durable vancomycin resistance, according to a study published August 28, 2024, in the open-access journal PLOS Pathogens by Samuel Blechman and Erik Wright from the University of Pittsburgh, USA.
Despite decades of widespread treatment with the antibiotic vancomycin, vancomycin resistance among the bacterium S. aureus is extremely uncommon—only 16 such cases have reported in the U.S. to date. Vancomycin resistance mutations enable bacteria to grow in the presence of vancomycin, but they do so at a cost. Vancomycin-resistant S. aureus (VRSA) strains grow more slowly and will often lose their resistance mutations if vancomycin ...